Skip to main content

US to buy Siga Technologies Inc's antiviral drug Tpoxx for $26m to fight monkeypox

The U.S. government is set to buy Siga Technologies Inc's antiviral drug Tpoxx, which was created to treat smallpox but has also been shown to combat monkeypox.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.